Showing 2 of 2 recruiting trials for “Nodular lymphocyte predominant Hodgkin lymphoma”
RecruitingNCT06098430 ↗
Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
👨⚕️ Valerie Crabtree, PhD, St. Jude Children's Research Hospital📍 5 sites📅 Started Apr 2024View details ↗
Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial
👨⚕️ Raphael E Steiner, University of Texas MD Anderson Cancer Center LAO📍 35 sites📅 Started Jan 2024View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →